Aliskiren: A Review of its Use in the Management of Hypertension

By Frampton James E.   Curran Monique P.  

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1767-1792

Adis International

Access to resources Recommend Favorite

Increased haemorrhage risk with idraparinux leads to trial termination

By  

Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Aliskiren: A Review of its Use as Monotherapy and as Combination Therapy in the Management of Hypertension

By Duggan Sean T.   Chwieduk Claudine M.   Curran Monique P.  

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 2011-2049

Adis International

Access to resources Recommend Favorite

Accounting for Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial

By Dallas Michael  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 4, 2008-07 ,pp. : 631-638

Taylor & Francis Ltd

Access to resources Recommend Favorite

Population Enrichment Designs: Case Study of a Large Multinational Trial

By Mehta Cyrus  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 831-845

Taylor & Francis Ltd

Access to resources Recommend Favorite